This is a Validated Antibody Database (VAD) review about mouse Krt19, based on 132 published articles (read how Labome selects the articles), using Krt19 antibody in all methods. It is aimed to help Labome visitors find the most suited Krt19 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Krt19 synonym: AI663979; CK-19; EndoC; K19; Krt-1.19; Krt1-19

Abcam
mouse monoclonal (A53-B/A2)
  • immunocytochemistry; pigs ; loading ...; fig 1a
Abcam Krt19 antibody (Abcam, ab7754) was used in immunocytochemistry on pigs samples (fig 1a). Sci Rep (2021) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig s1
Abcam Krt19 antibody (ABCAM, ab52625) was used in immunohistochemistry - paraffin section on human samples (fig s1). Adv Sci (Weinh) (2021) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry; mouse; 1:200; fig s1
Abcam Krt19 antibody (Abcam, ab52625) was used in immunohistochemistry on mouse samples at 1:200 (fig s1). Arch Toxicol (2021) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 1d
Abcam Krt19 antibody (Epitomics, AC-0073) was used in immunohistochemistry on mouse samples at 1:200 (fig 1d). Commun Biol (2021) ncbi
mouse monoclonal (A53-B/A2)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig s12b
  • immunocytochemistry; human; 1:100; loading ...; fig 1c
Abcam Krt19 antibody (Abcam, ab7754) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig s12b) and in immunocytochemistry on human samples at 1:100 (fig 1c). Science (2021) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig s12b
  • immunocytochemistry; human; 1:100; loading ...; fig 1c
Abcam Krt19 antibody (Abcam, ab52625) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig s12b) and in immunocytochemistry on human samples at 1:100 (fig 1c). Science (2021) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 2c
  • western blot; human; 1:5000; loading ...; fig 2a
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig s2c
  • western blot; mouse; 1:5000; loading ...; fig s2a
Abcam Krt19 antibody (Abcam, ab52625) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 2c), in western blot on human samples at 1:5000 (fig 2a), in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig s2c) and in western blot on mouse samples at 1:5000 (fig s2a). MBio (2020) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 5b
Abcam Krt19 antibody (Abcam, ab133496) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 5b). elife (2020) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig s2b
Abcam Krt19 antibody (Abcam, Ab52625) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig s2b). Cancer Cell (2020) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 3a
Abcam Krt19 antibody (Abcam, ab133496) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3a). Aging (Albany NY) (2019) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry; human; 1:200; loading ...; fig 5e
Abcam Krt19 antibody (abcam, ab52625) was used in immunohistochemistry on human samples at 1:200 (fig 5e). Nat Commun (2019) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry; mouse; 1:250; loading ...; fig 2e
Abcam Krt19 antibody (Abcam, ab133496) was used in immunohistochemistry on mouse samples at 1:250 (fig 2e). Carcinogenesis (2019) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunocytochemistry; human; 1:200; loading ...; fig 2c
Abcam Krt19 antibody (Abcam, ab52625) was used in immunocytochemistry on human samples at 1:200 (fig 2c). Stem Cell Res Ther (2019) ncbi
domestic rabbit monoclonal (EP1580Y)
  • western blot; human; loading ...; fig s4b
Abcam Krt19 antibody (Abcam, ab52625) was used in western blot on human samples (fig s4b). Cell (2019) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry; mouse; 1:800; loading ...; fig s4f
Abcam Krt19 antibody (Abcam, EPNCIR127B) was used in immunohistochemistry on mouse samples at 1:800 (fig s4f). Nature (2019) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunocytochemistry; mouse; 1:100; loading ...; fig 3b
  • western blot; mouse; 1:500; loading ...; fig 2b
Abcam Krt19 antibody (Abcam, ab52625) was used in immunocytochemistry on mouse samples at 1:100 (fig 3b) and in western blot on mouse samples at 1:500 (fig 2b). Int J Mol Sci (2019) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s3a
Abcam Krt19 antibody (Abcam, EPNCIR127B) was used in immunohistochemistry - frozen section on mouse samples (fig s3a). Nat Immunol (2019) ncbi
mouse monoclonal (A53-B/A2)
  • immunohistochemistry - frozen section; human; loading ...; fig 1c
Abcam Krt19 antibody (Abcam, A53-B/A2) was used in immunohistochemistry - frozen section on human samples (fig 1c). Cancer Res (2018) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1d
Abcam Krt19 antibody (Abcam, EP1580Y) was used in immunohistochemistry - frozen section on mouse samples (fig 1d). Science (2018) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry; mouse; 1:400; fig 4f
Abcam Krt19 antibody (Abcam, 52625) was used in immunohistochemistry on mouse samples at 1:400 (fig 4f). Nature (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; rat; loading ...; fig 94
In order to outline the protocols for antibodies used for immunohistochemical studies, Abcam Krt19 antibody (Abcam, ab15463) was used in immunohistochemistry on rat samples (fig 94). J Toxicol Pathol (2017) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s2a
In order to generate and characterize rat-sized pancreata composed of mouse-derived pluripotent stem cells, Abcam Krt19 antibody (Abcam, ab52625) was used in immunohistochemistry - paraffin section on mouse samples (fig s2a). Nature (2017) ncbi
mouse monoclonal (A53-B/A2)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3a
Abcam Krt19 antibody (Abcam, A53-B/A2) was used in immunohistochemistry - paraffin section on human samples (fig 3a). Lab Invest (2017) ncbi
mouse monoclonal (A53-B/A2)
  • immunocytochemistry; human; fig s1e
In order to define the interaction between LATS1/2 and the estrogen receptor signaling in breast cancer initiation., Abcam Krt19 antibody (Abcam, A53-B/A2) was used in immunocytochemistry on human samples (fig s1e). Nature (2017) ncbi
mouse monoclonal (A53-B/A2)
  • immunohistochemistry; human; 1:50; loading ...; fig 1b
In order to discuss changes in the expression of mitochondrial ribosomal proteins in cancer, Abcam Krt19 antibody (Abcam, ab7754) was used in immunohistochemistry on human samples at 1:50 (fig 1b). BMC Cancer (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:40; loading ...; fig 2e
In order to examine the liver regeneration process after physical partial hepatectomy, Abcam Krt19 antibody (Abcam, ab15463) was used in immunohistochemistry - frozen section on mouse samples at 1:40 (fig 2e). Lab Invest (2016) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry; mouse; 1:100; fig 10a
Abcam Krt19 antibody (Abcam, ab133496) was used in immunohistochemistry on mouse samples at 1:100 (fig 10a). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; fig 2
Abcam Krt19 antibody (Abcam, ab15463) was used in immunohistochemistry on mouse samples at 1:100 (fig 2). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:200; fig 2
  • western blot; human; 1:500; fig 5
Abcam Krt19 antibody (Abcam, ab53119) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2) and in western blot on human samples at 1:500 (fig 5). Int J Mol Med (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig s2
In order to characterize attenuation of liver fibrosis by direct reprogramming of hepatic myofibroblasts into hepatocytes in vivo, Abcam Krt19 antibody (Abcam, 15463) was used in immunohistochemistry - paraffin section on mouse samples (fig s2). Cell Stem Cell (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:800; fig 4
In order to describe protocols to generate specific pancreatic lineages from hPSCs, Abcam Krt19 antibody (Abcam, ab15463) was used in immunohistochemistry - paraffin section on human samples at 1:800 (fig 4). Methods (2016) ncbi
monoclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 1
In order to characterize a conditional knock out of ataxia telangiectasia-mutated as a mouse model of pancreatic ductal adenocarcinoma, Abcam Krt19 antibody (Abcam, ab7755) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 1). Nat Commun (2015) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 3
Abcam Krt19 antibody (Abcam, Ab133496) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 3). J Cell Mol Med (2015) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry - paraffin section; mouse; 1:5000; fig 4
In order to study inhibition of initiation of pancreatic ductal adenocarcinoma due to acinar differentiation determinant PTF1A, Abcam Krt19 antibody (Abcam, AB133496) was used in immunohistochemistry - paraffin section on mouse samples at 1:5000 (fig 4). elife (2015) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - paraffin section; human; 1:200; fig 4C
Abcam Krt19 antibody (Abcam, ab52625) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 4C). Sci Rep (2015) ncbi
monoclonal
  • western blot; mouse; fig 5
In order to investigate the effects of nicotinamide adenine dinucleotide phosphate reduced oxidase 4 in liver tissues from patients with NASH and mice with steatohepatitis, Abcam Krt19 antibody (abcam, Ab7755) was used in western blot on mouse samples (fig 5). Gastroenterology (2015) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry; mouse; 1:200
Abcam Krt19 antibody (abcam, ab133496) was used in immunohistochemistry on mouse samples at 1:200. PLoS ONE (2015) ncbi
mouse monoclonal (A53-B/A2)
  • immunocytochemistry; human; 1:25
  • immunohistochemistry; human; 1:25
In order to investigate the role of CEACAM6 in luminal, HER2-enriched, and basal-like breast cancers, Abcam Krt19 antibody (Abcam, A53-B/A2) was used in immunocytochemistry on human samples at 1:25 and in immunohistochemistry on human samples at 1:25. Am J Pathol (2014) ncbi
mouse monoclonal (A53-B/A2)
  • immunohistochemistry - paraffin section; human
  • immunohistochemistry - frozen section; mouse
Abcam Krt19 antibody (Abcam, ab7754) was used in immunohistochemistry - paraffin section on human samples and in immunohistochemistry - frozen section on mouse samples . PLoS ONE (2013) ncbi
Invitrogen
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 2b
Invitrogen Krt19 antibody (Lab Vision, MS-343-P) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2b). Sci Adv (2021) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
Invitrogen Krt19 antibody (eBioscience, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 4a). Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; rhesus macaque; 0.2 ug/ml; loading ...; fig 4g
Invitrogen Krt19 antibody (Thermo Fisher, 41-9003-82) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 0.2 ug/ml (fig 4g). Science (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1a
Invitrogen Krt19 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1a). Nat Cell Biol (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; fig 4, 5
Invitrogen Krt19 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples (fig 4, 5). Breast Cancer Res (2019) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; human; loading ...; fig s1b
In order to study the suppressive effect of DNAJB6 and Hsp70 on alpha-synuclein aggregation, Invitrogen Krt19 antibody (Thermo Fischer, MA5-13203) was used in immunocytochemistry on human samples (fig s1b). Sci Rep (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; tbl 2
In order to describe the differences between Xp11 translocation renal cell carcinoma and the corresponding mesenchymal neoplasm, Invitrogen Krt19 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; loading ...; fig 3d
In order to discuss a case of mixed adenoneuroendocrine carcinoma of stomach with tubular adenoma and well-differentiated neuroendocrine tumor in the primary tumor in the stomach, Invitrogen Krt19 antibody (Thermo Scientific, AE1-AE3) was used in immunohistochemistry on human samples (fig 3d). Case Rep Pathol (2016) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; mouse; loading ...; fig 3c
  • western blot; mouse; loading ...; fig 3d
In order to identify keratin-associated protein 5-5 as a driver of endothelial monolayer invasion, Invitrogen Krt19 antibody (Thermo Scientific, MA5-13203) was used in immunocytochemistry on mouse samples (fig 3c) and in western blot on mouse samples (fig 3d). Oncogene (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5b
In order to investigate inflammatory responses present at the breast cancer biopsy wound site, Invitrogen Krt19 antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 5b). Breast Cancer Res Treat (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; fig s3
In order to test if the operating room environment contains human skin bacteria that could be seeding C-section born infants, Invitrogen Krt19 antibody (Molecular Probes, 985542A) was used in immunohistochemistry - paraffin section on human samples (fig s3). Microbiome (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; fig s3
In order to determine how sensitivity is restored in resistant ovarian cancer cells by targeting the Ras-MAPK pathway by miR-634, Invitrogen Krt19 antibody (Neomarkers, MS-343-P) was used in immunohistochemistry on human samples (fig s3). Mol Cancer (2015) ncbi
mouse monoclonal (PAN-CK)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to describe functionally enriched ES cell transgenics, Invitrogen Krt19 antibody (Thermo Scientific, MA5-13203) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Sci Rep (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
In order to determine the desmoplastic interface in xenograft tumor in mice comprised of stromal and endothelial cells, Invitrogen Krt19 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Pathol Res Pract (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; mouse; 1:100; loading ...; tbl 2
In order to investigate if conditioned medium from proliferating fibroblasts induce a subset of hematopoietic cells to become adherent fibroblast-like cells, Invitrogen Krt19 antibody (eBioscience, 41-9003) was used in immunocytochemistry on mouse samples at 1:100 (tbl 2). J Cell Physiol (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 2
In order to study a northern New England hospital and increased utilization, verification, and clinical implications of immunocytochemistry, Invitrogen Krt19 antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry on human samples (tbl 2). Diagn Cytopathol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human
  • immunocytochemistry; human; 1 ul
Invitrogen Krt19 antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples and in immunocytochemistry on human samples at 1 ul. Nanomedicine (2015) ncbi
mouse monoclonal (PAN-CK)
  • western blot; human
In order to study the impact of TNF-alpha and IL-1beta on the inflammatory phenotype of cancer-associated fibroblasts and mesenchymal stem/stromal cells, Invitrogen Krt19 antibody (Thermo Fisher Scientific, MA5-13203) was used in western blot on human samples . Stem Cell Res Ther (2015) ncbi
mouse monoclonal (AE1/AE3)
In order to generate and characterize a thymic cell line derived from Channa striatus, Invitrogen Krt19 antibody (Invitrogen, AE1/AE3) was used . In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; domestic horse; 1:100
In order to discuss using induced pluripotent stem cells to promote wound healing in various animals, Invitrogen Krt19 antibody (Fisher Scientific, MA1-82041) was used in immunocytochemistry on domestic horse samples at 1:100. Equine Vet J (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 10-20 ug/ml
In order to identify biomarkers for nasopharyngeal carcinoma, Invitrogen Krt19 antibody (Lab.Vision, Ab-1) was used in immunohistochemistry - paraffin section on human samples at 10-20 ug/ml. Asian Pac J Cancer Prev (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen Krt19 antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen Krt19 antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; zebrafish ; 1:100; fig 5
In order to report that mice and zebrafish exposed to high-fat or high-cholesterol diets develop acute innate inflammatory responses in the intestine, Invitrogen Krt19 antibody (Thermo Fisher Scientific, MA1-82041) was used in flow cytometry on zebrafish samples at 1:100 (fig 5). Nat Commun (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 5
In order to determine the link between cell cycle control and proliferative potential of epidermal progenitor cells by the carboxy-terminus of p63, Invitrogen Krt19 antibody (ThermoFisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5). Development (2015) ncbi
mouse monoclonal (AE-1)
  • immunohistochemistry; human; ready-to-use
In order to describe a tumor from a patient with oncocytic cystadenoma, Invitrogen Krt19 antibody (Thermo Scientific, AE1) was used in immunohistochemistry on human samples at ready-to-use. Medicine (Baltimore) (2014) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry; human; ready-to-use
In order to describe a tumor from a patient with oncocytic cystadenoma, Invitrogen Krt19 antibody (Thermo Scientific, AE1) was used in immunohistochemistry on human samples at ready-to-use. Medicine (Baltimore) (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess the prognostic value of immunohistochemical markers in nonhuman primates, Invitrogen Krt19 antibody (Neo Markers, MS343) was used in immunohistochemistry - paraffin section on human samples at 1:100. Comp Med (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, Invitrogen Krt19 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Nat Cell Biol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen Krt19 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Hum Pathol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen Krt19 antibody (Thermo Fisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
In order to determine the role of myofibroblasts in salivary gland adenoid cystic carcinoma invasiveness, Invitrogen Krt19 antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on human samples . Histopathology (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human
In order to test if computed tomography-lymphography distinguishes sentinel nodes from non-sentinel nodes in patients with breast cancer, Invitrogen Krt19 antibody (Thermo, AE1/AE3) was used in immunohistochemistry on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
Invitrogen Krt19 antibody (Thermo Fisher, AE1/AE3) was used in immunocytochemistry on human samples . Biomed Mater (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human
In order to determine the predictive criteria of the size of nodal metastases with superparamagnetic iron oxide-enhanced MR imaging in breast cancer, Invitrogen Krt19 antibody (Thermoelectron, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to report the clinicopathological features of 9 breast malignant fibrous histiocytoma patients, Invitrogen Krt19 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Sci Rep (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:100; fig 1
Invitrogen Krt19 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples at 1:100 (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 1
In order to characterize a case of malignant ossifying fibromyxoid tumor in the tongue, Invitrogen Krt19 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (tbl 1). Head Face Med (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:200; fig 4
In order to present the third case of thymoma and the second invasive thymoma to metastasize to the cavernous sinus and adjacent to the pituitary, Invitrogen Krt19 antibody (Zymed, AE1-AE3) was used in immunohistochemistry on human samples at 1:200 (fig 4). Surg Neurol Int (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; fig 2
In order to present a case of not otherwise specified-type sarcoma with CD10 expression in the left breast, Invitrogen Krt19 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (fig 2). Diagn Pathol (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; Atlantic salmon; 1:50; fig 2
In order to study cell tropism of infectious salmon anemia virus, Invitrogen Krt19 antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on Atlantic salmon samples at 1:50 (fig 2). Virol J (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to review features of choroid plexus carcinoma, Invitrogen Krt19 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Med Sci Monit (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse
In order to investigate the positioning of taste buds in circumvallate papilla and branching morphogenesis of von Ebners' gland in tongue development, Invitrogen Krt19 antibody (Thermo Scientific, MS-343) was used in immunohistochemistry - paraffin section on mouse samples . Anat Cell Biol (2011) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - paraffin section; human; 1:100
  • immunocytochemistry; human; 1:100
In order to investigate epithelial to mesenchymal transition during metastasis of pancreatic cancer, Invitrogen Krt19 antibody (Labvision, MS-149) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunocytochemistry on human samples at 1:100. Br J Cancer (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200
In order to examine the suitability of PAXgene tissue fixation for (immuno)histological methods, Invitrogen Krt19 antibody (Neomarkers, MS 343-P) was used in immunohistochemistry - paraffin section on human samples at 1:200. PLoS ONE (2011) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 0.4 ug/ul; fig 1
In order to develop an in vitro model for experimental studies of cancer cell invasion, Invitrogen Krt19 antibody (NeoMarkers, MS-343) was used in immunohistochemistry on human samples at 0.4 ug/ul (fig 1). Eur J Oral Sci (2010) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen Krt19 antibody (Zymed, AE1) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (AE-1)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen Krt19 antibody (Zymed, AE1) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen Krt19 antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200
In order to discuss the morphological diversity of glioblastomas, Invitrogen Krt19 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:200. Cancer (2008) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; fig 5
In order to investigate the effect of COX-2 overexpression on inhibiting proliferation, apoptosis and differentiation, Invitrogen Krt19 antibody (Lab Vision, MS-343-P) was used in western blot on human samples (fig 5). Int J Cancer (2005) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen Krt19 antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:80; tbl 1
In order to describe four cases of oncocytic adrenocortical carcinomas, Invitrogen Krt19 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:80 (tbl 1). Pathol Int (2004) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; 1:1000; fig 2
In order to study how cell-matrix interactions influence the invasive behavior of a novel, primary peritoneal carcinosarcoma cell line, Invitrogen Krt19 antibody (Zymed, AE1/AE3) was used in western blot on human samples at 1:1000 (fig 2). Gynecol Oncol (2003) ncbi
Santa Cruz Biotechnology
mouse monoclonal (A-3)
  • western blot; mouse; 1:1000; loading ...; fig s2i
Santa Cruz Biotechnology Krt19 antibody (Santa Cruz, sc-376126) was used in western blot on mouse samples at 1:1000 (fig s2i). Nat Commun (2020) ncbi
mouse monoclonal (A-3)
  • immunohistochemistry; mouse; 1:300; loading ...
Santa Cruz Biotechnology Krt19 antibody (Santa Cruz, sc-376126) was used in immunohistochemistry on mouse samples at 1:300. Nature (2019) ncbi
mouse monoclonal (BA17)
  • immunohistochemistry - paraffin section; dogs; 1:200; loading ...; fig 3c
Santa Cruz Biotechnology Krt19 antibody (Santa Cruz Biotechnology, BA17) was used in immunohistochemistry - paraffin section on dogs samples at 1:200 (fig 3c). J Vet Med Sci (2019) ncbi
mouse monoclonal (A-3)
  • immunohistochemistry - frozen section; rat; loading ...; fig s4a
Santa Cruz Biotechnology Krt19 antibody (SantaCruz, sc-376126) was used in immunohistochemistry - frozen section on rat samples (fig s4a). Oncotarget (2017) ncbi
mouse monoclonal (A-3)
  • immunohistochemistry; human; 1:500; fig 1c
Santa Cruz Biotechnology Krt19 antibody (SantaCruz, sc-376126) was used in immunohistochemistry on human samples at 1:500 (fig 1c). Cancer Sci (2016) ncbi
mouse monoclonal (BA17)
  • western blot; human; loading ...; fig 1b
Santa Cruz Biotechnology Krt19 antibody (Santa Cruz, SC-53258) was used in western blot on human samples (fig 1b). Oncogene (2017) ncbi
Novus Biologicals
domestic rabbit polyclonal (OX-6)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 2b
Novus Biologicals Krt19 antibody (Novus, NB100-687) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2b). Sci Adv (2021) ncbi
domestic rabbit polyclonal (OX-6)
  • immunocytochemistry; human; 1:100; loading ...; fig 2a
Novus Biologicals Krt19 antibody (Novus, NB100-687) was used in immunocytochemistry on human samples at 1:100 (fig 2a). Sci Rep (2020) ncbi
domestic rabbit polyclonal (OX-6)
In order to study the effect of bile acids on mesenchymal stem cells in liver, Novus Biologicals Krt19 antibody (Novus Biologicals, NB100-687) was used . Sci Rep (2015) ncbi
Developmental Studies Hybridoma Bank
rat monoclonal (TROMA-III)
  • immunohistochemistry; mouse; loading ...; fig 1j
Developmental Studies Hybridoma Bank Krt19 antibody (Developmental Studies Hybridoma Bank (DSHB), TROMAIII) was used in immunohistochemistry on mouse samples (fig 1j). Cell Rep (2021) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry; human; loading ...; fig 4g
Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, TROMAIII) was used in immunohistochemistry on human samples (fig 4g). Commun Biol (2021) ncbi
rat monoclonal (TROMA-III)
  • immunocytochemistry; mouse; fig 7d
  • immunohistochemistry; mouse; 1:100; fig 6i
Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, TROMA-III) was used in immunocytochemistry on mouse samples (fig 7d) and in immunohistochemistry on mouse samples at 1:100 (fig 6i). Cancer Res (2021) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry; mouse; loading ...; fig 1b
Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, TROMA-III) was used in immunohistochemistry on mouse samples (fig 1b). Cancer Discov (2021) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry; human; loading ...; fig 5f
  • immunohistochemistry; mouse; loading ...; fig 5f
Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, Troma III) was used in immunohistochemistry on human samples (fig 5f) and in immunohistochemistry on mouse samples (fig 5f). elife (2021) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 1f
Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 1f). Int J Mol Sci (2021) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 2b
Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 2b). elife (2021) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig s12b
  • immunocytochemistry; human; 1:100; loading ...; fig 1c
Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, TROMA III) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig s12b) and in immunocytochemistry on human samples at 1:100 (fig 1c). Science (2021) ncbi
rat monoclonal (TROMA-III)
  • immunocytochemistry; mouse; 1:200; loading ...; fig s3d
Developmental Studies Hybridoma Bank Krt19 antibody (Developmental Studies Hybridoma Bank, TROMA-III) was used in immunocytochemistry on mouse samples at 1:200 (fig s3d). Development (2019) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1d
  • western blot; mouse; loading ...; fig 4c
Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples (fig 1d) and in western blot on mouse samples (fig 4c). Cell Death Differ (2019) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:3; loading ...; fig 5c
Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples at 1:3 (fig 5c). Cell Death Dis (2018) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry; mouse; loading ...; fig 3b
Developmental Studies Hybridoma Bank Krt19 antibody (DHSB, TROMA-III) was used in immunohistochemistry on mouse samples (fig 3b). Gastroenterology (2018) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 1d
Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 1d). Cancer Cell (2017) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s2b
Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples (fig s2b). J Clin Invest (2017) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1b
Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, Troma-III) was used in immunohistochemistry - frozen section on mouse samples (fig 1b). J Exp Med (2017) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry; mouse; loading ...; fig 1d
In order to investigate the role of mitogen-activated protein kinase in pancreatitis, Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, Troma-III) was used in immunohistochemistry on mouse samples (fig 1d). Cell Mol Gastroenterol Hepatol (2017) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 1d
In order to examine the expression and role of major facilitator super family domain containing 2a in liver regeneration, Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1d). Nat Commun (2016) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry; human; loading ...; fig 1b
Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, TROMA-III) was used in immunohistochemistry on human samples (fig 1b). Oncotarget (2016) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 3d
In order to discuss the role of myeloid cells in pancreatic cancer pathogenesis, Developmental Studies Hybridoma Bank Krt19 antibody (hybridoma bank, TromaIII) was used in immunohistochemistry on mouse samples at 1:100 (fig 3d). Gut (2017) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - frozen section; mouse; fig 1
In order to analyze mediation of stellate and endothelial cell interactions during hepatic fibrosis due to murine junctional adhesion molecules JAM-B and JAM-C, Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - frozen section on mouse samples (fig 1). Cell Adh Migr (2016) ncbi
rat monoclonal (TROMA-III)
  • immunocytochemistry; mouse; 1:10; fig 4
In order to study a decrease in glutathione and SOX17 and toxin biliastresone that causes mouse extrahepatic cholangiocyte damage and fibrosis, Developmental Studies Hybridoma Bank Krt19 antibody (Developmental Studies Hybridoma Bank, TROMAIII) was used in immunocytochemistry on mouse samples at 1:10 (fig 4). Hepatology (2016) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s2c
Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples (fig s2c). Gastroenterology (2016) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s2
Developmental Studies Hybridoma Bank Krt19 antibody (Developmental Studies Hybridoma Bank, TROMAIII) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s2). Oncogene (2016) ncbi
rat monoclonal (TROMA-III)
  • immunocytochemistry; mouse; fig 2
In order to follow the presence of K14+ compound niches present in mouse cornea early after birth through expansion after debridement wounds, Developmental Studies Hybridoma Bank Krt19 antibody (Developmental Studies Hybridoma Bank, Troma III) was used in immunocytochemistry on mouse samples (fig 2). Dev Dyn (2016) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; fig 4
  • immunohistochemistry - paraffin section; human; fig 4
In order to study hepatocellular carcinoma and ectopic lymphoid structures function as microniches for tumor progenitor cells, Developmental Studies Hybridoma Bank Krt19 antibody (Developmental Studies Hybridoma Bank, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples (fig 4) and in immunohistochemistry - paraffin section on human samples (fig 4). Nat Immunol (2015) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig s5e
In order to report that an inhibitor of the bromodomain and extraterminal family of proteins suppresses pancreatic ductal adenocarcinoma, Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, TromaIII) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig s5e). Nat Med (2015) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; fig 1
Developmental Studies Hybridoma Bank Krt19 antibody (Developmental Studies Hybridoma Bank, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Genes Dev (2015) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; fig 2
Developmental Studies Hybridoma Bank Krt19 antibody (Developmental Studies Hybridoma Bank, TROMAIII) was used in immunohistochemistry - paraffin section on mouse samples (fig 2). Oncotarget (2015) ncbi
rat monoclonal (TROMA-III)
  • immunocytochemistry; human; 1:20
Developmental Studies Hybridoma Bank Krt19 antibody (Developmental Studies Hybridoma Bank, Troma-III) was used in immunocytochemistry on human samples at 1:20. Front Cell Dev Biol (2015) ncbi
rat monoclonal (TROMA-III)
  • western blot; mouse; 1:500; fig s3
In order to research aggravation of murine caerulein-induced acute pancreatitis and the favoring of acinar keratin granule formation due to epiplakin deficiency, Developmental Studies Hybridoma Bank Krt19 antibody (Developmental Studies Hybridoma Bank, Troma III) was used in western blot on mouse samples at 1:500 (fig s3). PLoS ONE (2014) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 2
Developmental Studies Hybridoma Bank Krt19 antibody (Developmental Studies Hybridoma Bank, TROMA-III-c) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 2). Oncogene (2015) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; fig s2
Developmental Studies Hybridoma Bank Krt19 antibody (Developmental Studies Hybridoma Bank, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples (fig s2). Cell Death Differ (2014) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:400; fig 7
Developmental Studies Hybridoma Bank Krt19 antibody (Hydroma Bank, Troma III) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 7). PLoS ONE (2014) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; rat; 1:750
Developmental Studies Hybridoma Bank Krt19 antibody (Hybridoma Bank, Troma-III) was used in immunohistochemistry - paraffin section on rat samples at 1:750. Alcohol Clin Exp Res (2014) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse
Developmental Studies Hybridoma Bank Krt19 antibody (Developmental Studies Hybridoma Bank, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples . Genes Dev (2013) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:200
In order to study the roles of GATA4 and GATA6 in mouse pancreas organogenesis, Developmental Studies Hybridoma Bank Krt19 antibody (DSHB, TROMA III) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. J Clin Invest (2012) ncbi
Articles Reviewed
  1. Molina L, Zhu J, Li Q, Pradhan Sundd T, Krutsenko Y, Sayed K, et al. Compensatory hepatic adaptation accompanies permanent absence of intrahepatic biliary network due to YAP1 loss in liver progenitors. Cell Rep. 2021;36:109310 pubmed publisher
  2. Bailey K, Cartwright S, Patel N, Remmers N, Lazenby A, Hollingsworth M, et al. Porcine pancreatic ductal epithelial cells transformed with KRASG12D and SV40T are tumorigenic. Sci Rep. 2021;11:13436 pubmed publisher
  3. Pocaterra A, Scattolin G, Romani P, Ament C, Ribback S, Chen X, et al. Fascin1 empowers YAP mechanotransduction and promotes cholangiocarcinoma development. Commun Biol. 2021;4:763 pubmed publisher
  4. Zhao Y, Li Z, Zhu Y, Fu J, Zhao X, Zhang Y, et al. Single-Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids. Adv Sci (Weinh). 2021;8:e2003897 pubmed publisher
  5. Barthet V, Brucoli M, Ladds M, Nössing C, Kiourtis C, Baudot A, et al. Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver. Sci Adv. 2021;7: pubmed publisher
  6. Howell L, Jenkins R, Lynch S, Duckworth C, Kevin Park B, Goldring C. Proteomic profiling of murine biliary-derived hepatic organoids and their capacity for drug disposition, bioactivation and detoxification. Arch Toxicol. 2021;95:2413-2430 pubmed publisher
  7. Kemp S, Carpenter E, Steele N, Donahue K, Nwosu Z, Pacheco A, et al. Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB-Mediated Production of CXCL1. Cancer Res. 2021;81:4305-4318 pubmed publisher
  8. Flowers B, Xu H, Mulligan A, Hanson K, Seoane J, Vogel H, et al. Cell of Origin Influences Pancreatic Cancer Subtype. Cancer Discov. 2021;11:660-677 pubmed publisher
  9. Hendley A, Rao A, Leonhardt L, Ashe S, Smith J, Giacometti S, et al. Single-cell transcriptome analysis defines heterogeneity of the murine pancreatic ductal tree. elife. 2021;10: pubmed publisher
  10. Hsieh M, Weng C, Lin Y, Wu C, Chen L, Cheng K. Inhibition of β-Catenin Activity Abolishes LKB1 Loss-Driven Pancreatic Cystadenoma in Mice. Int J Mol Sci. 2021;22: pubmed publisher
  11. Hunter S, McIntosh B, Shi Y, Sperberg R, Funatogawa C, Labanieh L, et al. An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy. Commun Biol. 2021;4:452 pubmed publisher
  12. Hankeova S, Salplachta J, Zikmund T, Kavkova M, Van Hul N, Brinek A, et al. DUCT reveals architectural mechanisms contributing to bile duct recovery in a mouse model for Alagille syndrome. elife. 2021;10: pubmed publisher
  13. Sampaziotis F, Muraro D, Tysoe O, Sawiak S, Beach T, Godfrey E, et al. Cholangiocyte organoids can repair bile ducts after transplantation in the human liver. Science. 2021;371:839-846 pubmed publisher
  14. Biasci D, Smoragiewicz M, Connell C, Wang Z, Gao Y, Thaventhiran J, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc Natl Acad Sci U S A. 2020;117:28960-28970 pubmed publisher
  15. Sepe L, Hartl K, Iftekhar A, Berger H, Kumar N, Goosmann C, et al. Genotoxic Effect of Salmonella Paratyphi A Infection on Human Primary Gallbladder Cells. MBio. 2020;11: pubmed publisher
  16. Lau A, Li Z, Danai L, Westermark A, Darnell A, Ferreira R, et al. Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma. elife. 2020;9: pubmed publisher
  17. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed publisher
  18. Gaglia G, Rashid R, Yapp C, Joshi G, Li C, Lindquist S, et al. HSF1 phase transition mediates stress adaptation and cell fate decisions. Nat Cell Biol. 2020;22:151-158 pubmed publisher
  19. Cheung E, DeNicola G, Nixon C, Blyth K, Labuschagne C, Tuveson D, et al. Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer. Cancer Cell. 2020;37:168-182.e4 pubmed publisher
  20. Rahman M, Wruck W, Spitzhorn L, Nguyen L, Bohndorf M, Martins S, et al. The FGF, TGFβ and WNT axis Modulate Self-renewal of Human SIX2+ Urine Derived Renal Progenitor Cells. Sci Rep. 2020;10:739 pubmed publisher
  21. Wang G, Xu J, Zhao J, Yin W, Liu D, Chen W, et al. Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice. Nat Commun. 2020;11:220 pubmed publisher
  22. Shen J, Zhou Y, Zhang X, Peng W, Peng C, Zhou Q, et al. Loss of FoxA2 accelerates neoplastic changes in the intrahepatic bile duct partly via the MAPK signaling pathway. Aging (Albany NY). 2019;11:9280-9294 pubmed publisher
  23. Ramani V, Lemaire C, Triboulet M, Casey K, Heirich K, Renier C, et al. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Breast Cancer Res. 2019;21:98 pubmed publisher
  24. Segal J, Kent D, Wesche D, Ng S, Serra M, Oulès B, et al. Single cell analysis of human foetal liver captures the transcriptional profile of hepatobiliary hybrid progenitors. Nat Commun. 2019;10:3350 pubmed publisher
  25. Mishra A, Emamgholi F, Erlangga Z, Hartleben B, Unger K, Wolff K, et al. Generation of focal mutations and large genomic deletions in the pancreas using inducible in vivo genome editing. Carcinogenesis. 2019;: pubmed publisher
  26. Zhou H, Wang L, Zhang C, Hu J, Chen J, Du W, et al. Feasibility of repairing full-thickness skin defects by iPSC-derived epithelial stem cells seeded on a human acellular amniotic membrane. Stem Cell Res Ther. 2019;10:155 pubmed publisher
  27. Prior N, Hindley C, Rost F, Meléndez E, Lau W, Gottgens B, et al. Lgr5+ stem and progenitor cells reside at the apex of a heterogeneous embryonic hepatoblast pool. Development. 2019;146: pubmed publisher
  28. Guiu J, Hannezo E, Yui S, Demharter S, Ulyanchenko S, Maimets M, et al. Tracing the origin of adult intestinal stem cells. Nature. 2019;570:107-111 pubmed publisher
  29. Krishna Subramanian S, Singer S, Armaka M, Banales J, Hölzer K, Schirmacher P, et al. RIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injury. Cell Death Differ. 2019;: pubmed publisher
  30. Jeppesen D, Fenix A, Franklin J, Higginbotham J, Zhang Q, Zimmerman L, et al. Reassessment of Exosome Composition. Cell. 2019;177:428-445.e18 pubmed publisher
  31. Lee J, Stone M, Porrett P, Thomas S, Komar C, Li J, et al. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019;567:249-252 pubmed publisher
  32. Mona M, Miller R, Li H, Park Y, Zaman R, Yang L, et al. MIST1, an Inductive Signal for Salivary Amylase in Mesenchymal Stem Cells. Int J Mol Sci. 2019;20: pubmed publisher
  33. Liu M, O Connor R, Trefely S, Graham K, Snyder N, Beatty G. Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal. Nat Immunol. 2019;20:265-275 pubmed publisher
  34. Lee S, Ji H, Baek S, Lee A, Kim M, Park S, et al. Feline-type cystic basal cell tumor filled with abundant melanin pigment-rich fluid in a dog. J Vet Med Sci. 2019;81:269-273 pubmed publisher
  35. Gorth D, Shapiro I, Risbud M. Transgenic mice overexpressing human TNF-α experience early onset spontaneous intervertebral disc herniation in the absence of overt degeneration. Cell Death Dis. 2018;10:7 pubmed publisher
  36. Wu T, Xu K, Martinek J, Young R, Banchereau R, George J, et al. IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer. Cancer Res. 2018;78:5243-5258 pubmed publisher
  37. Pommier A, Anaparthy N, Memos N, Kelley Z, Gouronnec A, Yan R, et al. Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases. Science. 2018;360: pubmed publisher
  38. He P, Yang J, Yang V, Bialkowska A. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice. Gastroenterology. 2018;154:1494-1508.e13 pubmed publisher
  39. Qin D, Yan Y, Hu B, Zhang W, Li H, Li X, et al. Wisp2 disruption represses Cxcr4 expression and inhibits BMSCs homing to injured liver. Oncotarget. 2017;8:98823-98836 pubmed publisher
  40. Mello S, Valente L, Raj N, Seoane J, Flowers B, McClendon J, et al. A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer. Cancer Cell. 2017;32:460-473.e6 pubmed publisher
  41. Aprile F, Källstig E, Limorenko G, Vendruscolo M, Ron D, Hansen C. The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation. Sci Rep. 2017;7:9039 pubmed publisher
  42. Van T, Polykratis A, Straub B, Kondylis V, Papadopoulou N, Pasparakis M. Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis. J Clin Invest. 2017;127:2662-2677 pubmed publisher
  43. Kamerkar S, LeBleu V, Sugimoto H, Yang S, Ruivo C, Melo S, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546:498-503 pubmed publisher
  44. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  45. Wang X, Xia Q, Ni H, Ye S, Li R, Wang X, et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Hum Pathol. 2017;63:190-200 pubmed publisher
  46. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  47. Yamaguchi T, Sato H, Kato Itoh M, Goto T, Hara H, Sanbo M, et al. Interspecies organogenesis generates autologous functional islets. Nature. 2017;542:191-196 pubmed publisher
  48. Roy I, Boyle K, Vonderhaar E, Zimmerman N, Gorse E, Mackinnon A, et al. Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma. Lab Invest. 2017;97:302-317 pubmed publisher
  49. Halbrook C, Wen H, Ruggeri J, Takeuchi K, Zhang Y, di Magliano M, et al. Mitogen-activated Protein Kinase Kinase Activity Maintains Acinar-to-Ductal Metaplasia and Is Required for Organ Regeneration in Pancreatitis. Cell Mol Gastroenterol Hepatol. 2017;3:99-118 pubmed publisher
  50. Britschgi A, Duss S, Kim S, Couto J, Brinkhaus H, Koren S, et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature. 2017;541:541-545 pubmed publisher
  51. Sørensen K, Meldgaard T, Melchjorsen C, Fridriksdottir A, Pedersen H, Petersen O, et al. Upregulation of Mrps18a in breast cancer identified by selecting phage antibody libraries on breast tissue sections. BMC Cancer. 2017;17:19 pubmed publisher
  52. De Luca Johnson J, Zenali M. A Previously Undescribed Presentation of Mixed Adenoneuroendocrine Carcinoma. Case Rep Pathol. 2016;2016:9063634 pubmed
  53. Pu W, Zhang H, Huang X, Tian X, He L, Wang Y, et al. Mfsd2a+ hepatocytes repopulate the liver during injury and regeneration. Nat Commun. 2016;7:13369 pubmed publisher
  54. Li Q, Wang H, Zogopoulos G, Shao Q, Dong K, Lv F, et al. Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma. Oncotarget. 2016;7:77838-77853 pubmed publisher
  55. Suzuki Y, Katagiri H, Wang T, Kakisaka K, Kume K, Nishizuka S, et al. Ductular reactions in the liver regeneration process with local inflammation after physical partial hepatectomy. Lab Invest. 2016;96:1211-1222 pubmed publisher
  56. Muzumdar M, Dorans K, Chung K, Robbins R, Tammela T, Gocheva V, et al. Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers. Nat Commun. 2016;7:12685 pubmed publisher
  57. Yoshida M, Miyasaka Y, Ohuchida K, Okumura T, Zheng B, Torata N, et al. Calpain inhibitor calpeptin suppresses pancreatic cancer by disrupting cancer-stromal interactions in a mouse xenograft model. Cancer Sci. 2016;107:1443-1452 pubmed publisher
  58. Zhang Y, Velez Delgado A, Mathew E, Li D, Mendez F, Flannagan K, et al. Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer. Gut. 2017;66:124-136 pubmed publisher
  59. Berens E, Sharif G, Schmidt M, Yan G, Shuptrine C, Weiner L, et al. Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion. Oncogene. 2017;36:593-605 pubmed publisher
  60. Saha S, Choi H, Kim B, Dayem A, Yang G, Kim K, et al. KRT19 directly interacts with β-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties. Oncogene. 2017;36:332-349 pubmed publisher
  61. Szalayova G, Ogrodnik A, Spencer B, Wade J, Bunn J, Ambaye A, et al. Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast Cancer Res Treat. 2016;157:461-74 pubmed publisher
  62. Hintermann E, Bayer M, Ehser J, Aurrand Lions M, Pfeilschifter J, Imhof B, et al. Murine junctional adhesion molecules JAM-B and JAM-C mediate endothelial and stellate cell interactions during hepatic fibrosis. Cell Adh Migr. 2016;10:419-33 pubmed publisher
  63. Waisbourd Zinman O, Koh H, Tsai S, Lavrut P, Dang C, Zhao X, et al. The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17. Hepatology. 2016;64:880-93 pubmed publisher
  64. Hong X, Zhang J, Wu Q, Wang W, Ye A, Song W, et al. Challenges in detecting pre-malignant pancreatic lesions during acute pancreatitis using a serum microRNA assay: a study based on KrasG12D transgenic mice. Oncotarget. 2016;7:22700-10 pubmed publisher
  65. Yang S, Sun Y, Geng Z, Ma K, Sun X, Fu X. Abnormalities in the basement membrane structure promote basal keratinocytes in the epidermis of hypertrophic scars to adopt a proliferative phenotype. Int J Mol Med. 2016;37:1263-73 pubmed publisher
  66. Seifert L, Werba G, Tiwari S, Giao Ly N, Nguy S, Alothman S, et al. Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. Gastroenterology. 2016;150:1659-1672.e5 pubmed publisher
  67. Song G, Pacher M, Balakrishnan A, Yuan Q, Tsay H, Yang D, et al. Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver Fibrosis. Cell Stem Cell. 2016;18:797-808 pubmed publisher
  68. Shin H, Pei Z, Martinez K, Rivera Viñas J, Méndez K, Cavallin H, et al. The first microbial environment of infants born by C-section: the operating room microbes. Microbiome. 2015;3:59 pubmed publisher
  69. Diersch S, Wirth M, Schneeweis C, Jörs S, Geisler F, Siveke J, et al. Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells. Oncogene. 2016;35:3880-6 pubmed publisher
  70. van Jaarsveld M, van Kuijk P, Boersma A, Helleman J, Van Ijcken W, Mathijssen R, et al. miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway. Mol Cancer. 2015;14:196 pubmed publisher
  71. Gao L, Jiang Y, Mu L, Liu Y, Wang F, Wang P, et al. Efficient Generation of Mice with Consistent Transgene Expression by FEEST. Sci Rep. 2015;5:16284 pubmed publisher
  72. Jung M, Ryu Y, Kang G. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice. Pathol Res Pract. 2015;211:925-30 pubmed publisher
  73. Li Y, Adomat H, Guns E, Hojabrpour P, Duronio V, Curran T, et al. Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor. J Cell Physiol. 2016;231:1350-63 pubmed publisher
  74. Korytnikov R, Nostro M. Generation of polyhormonal and multipotent pancreatic progenitor lineages from human pluripotent stem cells. Methods. 2016;101:56-64 pubmed publisher
  75. Pajoohesh Ganji A, Pal Ghosh S, Tadvalkar G, Stepp M. K14 + compound niches are present on the mouse cornea early after birth and expand after debridement wounds. Dev Dyn. 2016;245:132-43 pubmed publisher
  76. Finkin S, Yuan D, Stein I, Taniguchi K, Weber A, Unger K, et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat Immunol. 2015;16:1235-44 pubmed publisher
  77. Mazur P, Herner A, Mello S, Wirth M, Hausmann S, Sánchez Rivera F, et al. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Nat Med. 2015;21:1163-71 pubmed publisher
  78. Sawitza I, Kordes C, Götze S, Herebian D, Häussinger D. Bile acids induce hepatic differentiation of mesenchymal stem cells. Sci Rep. 2015;5:13320 pubmed publisher
  79. Russell R, Perkhofer L, Liebau S, Lin Q, Lechel A, Feld F, et al. Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition. Nat Commun. 2015;6:7677 pubmed publisher
  80. Chiou S, Winters I, Wang J, Naranjo S, Dudgeon C, Tamburini F, et al. Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing. Genes Dev. 2015;29:1576-85 pubmed publisher
  81. Malik I, Stange I, Martius G, Cameron S, Rave Fränk M, Hess C, et al. Role of PECAM-1 in radiation-induced liver inflammation. J Cell Mol Med. 2015;19:2441-52 pubmed publisher
  82. Krah N, De La O J, Swift G, Hoang C, Willet S, Chen Pan F, et al. The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma. elife. 2015;4: pubmed publisher
  83. Sauter J, Ambaye A, Mount S. Increased utilization, verification, and clinical implications of immunocytochemistry: Experience in a northern New England hospital. Diagn Cytopathol. 2015;43:688-95 pubmed publisher
  84. Kwon J, NABINGER S, Vega Z, Sahu S, Alluri R, Abdul Sater Z, et al. Pathophysiological role of microRNA-29 in pancreatic cancer stroma. Sci Rep. 2015;5:11450 pubmed publisher
  85. Muhanna N, Mepham A, Mohamadi R, Chan H, Khan T, Akens M, et al. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model. Nanomedicine. 2015;11:1613-20 pubmed publisher
  86. Katanov C, Lerrer S, Liubomirski Y, Leider Trejo L, Meshel T, Bar J, et al. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-? and the NF-?B pathway. Stem Cell Res Ther. 2015;6:87 pubmed publisher
  87. Bettaieb A, Jiang J, Sasaki Y, Chao T, Kiss Z, Chen X, et al. Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice. Gastroenterology. 2015;149:468-80.e10 pubmed publisher
  88. Sood N, Chaudhary D, Pradhan P, Verma D, Raja Swaminathan T, Kushwaha B, et al. Establishment and characterization of a continuous cell line from thymus of striped snakehead, Channa striatus (Bloch 1793). In Vitro Cell Dev Biol Anim. 2015;51:787-96 pubmed publisher
  89. Li X, Tao J, Cigliano A, Sini M, Calderaro J, Azoulay D, et al. Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver. Oncotarget. 2015;6:10102-15 pubmed
  90. Lee J, Garbe J, Vrba L, Miyano M, Futscher B, Stampfer M, et al. Age and the means of bypassing stasis influence the intrinsic subtype of immortalized human mammary epithelial cells. Front Cell Dev Biol. 2015;3:13 pubmed publisher
  91. Bogaerts E, Heindryckx F, Devisscher L, Paridaens A, Vandewynckel Y, Van den Bussche A, et al. Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumors. PLoS ONE. 2015;10:e0119555 pubmed publisher
  92. Aguiar C, Therrien J, Lemire P, Segura M, Smith L, Theoret C. Differentiation of equine induced pluripotent stem cells into a keratinocyte lineage. Equine Vet J. 2016;48:338-45 pubmed publisher
  93. Ahmed H, Abdul Gader Suliman R, Abd El Aziz M, Alshammari F. Immunohistochemical expression of cytokeratins and epithelial membrane protein 2 in nasopharyngeal carcinoma and its potential implications. Asian Pac J Cancer Prev. 2015;16:653-6 pubmed
  94. Zheng L, Cardaci S, Jerby L, MacKenzie E, Sciacovelli M, Johnson T, et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat Commun. 2015;6:6001 pubmed publisher
  95. Progatzky F, Sangha N, Yoshida N, McBrien M, Cheung J, Shia A, et al. Dietary cholesterol directly induces acute inflammasome-dependent intestinal inflammation. Nat Commun. 2014;5:5864 pubmed publisher
  96. Suzuki D, Sahu R, Leu N, Senoo M. The carboxy-terminus of p63 links cell cycle control and the proliferative potential of epidermal progenitor cells. Development. 2015;142:282-90 pubmed publisher
  97. BaÅŸak K, KiroÄŸlu K. Multiple oncocytic cystadenoma with intraluminal crystalloids in parotid gland: case report. Medicine (Baltimore). 2014;93:e246 pubmed publisher
  98. Beck A, Brooks A, Zeiss C. Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta). Comp Med. 2014;64:314-22 pubmed
  99. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  100. Wögenstein K, Szabo S, Lunova M, Wiche G, Haybaeck J, Strnad P, et al. Epiplakin deficiency aggravates murine caerulein-induced acute pancreatitis and favors the formation of acinar keratin granules. PLoS ONE. 2014;9:e108323 pubmed publisher
  101. Li L, Fan X, Xia Q, Rao Q, Liu B, Yu B, et al. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis. Hum Pathol. 2014;45:2247-54 pubmed publisher
  102. Costache M, Pătraşcu O, Dumitru A, Costache D, Voinea L, Simionescu O, et al. Histopathological findings concerning ocular melanomas. Rom J Morphol Embryol. 2014;55:649-53 pubmed
  103. Morris S, Carter K, Baek J, Koszarek A, Yeh M, Knoblaugh S, et al. TGF-? signaling alters the pattern of liver tumorigenesis induced by Pten inactivation. Oncogene. 2015;34:3273-82 pubmed publisher
  104. Guan H, Tan J, Zhang F, Gao L, Bai L, Qi D, et al. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12. Histopathology. 2015;66:781-90 pubmed publisher
  105. Ehlken H, Krishna Subramanian S, Ochoa Callejero L, Kondylis V, Nadi N, Straub B, et al. Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout. Cell Death Differ. 2014;21:1721-32 pubmed publisher
  106. Balk Møller E, Kim J, Hopkinson B, Timmermans Wielenga V, Petersen O, Villadsen R. A marker of endocrine receptor-positive cells, CEACAM6, is shared by two major classes of breast cancer: luminal and HER2-enriched. Am J Pathol. 2014;184:1198-208 pubmed publisher
  107. Karaca G, Swiderska Syn M, Xie G, Syn W, Krüger L, Machado M, et al. TWEAK/Fn14 signaling is required for liver regeneration after partial hepatectomy in mice. PLoS ONE. 2014;9:e83987 pubmed publisher
  108. Motomura K, Sumino H, Noguchi A, Horinouchi T, Nakanishi K. Sentinel nodes identified by computed tomography-lymphography accurately stage the axilla in patients with breast cancer. BMC Med Imaging. 2013;13:42 pubmed publisher
  109. Chan I, Guy C, Machado M, Wank A, Kadiyala V, Michelotti G, et al. Alcohol activates the hedgehog pathway and induces related procarcinogenic processes in the alcohol-preferring rat model of hepatocarcinogenesis. Alcohol Clin Exp Res. 2014;38:787-800 pubmed publisher
  110. Bulysheva A, Bowlin G, Petrova S, Yeudall W. Enhanced chemoresistance of squamous carcinoma cells grown in 3D cryogenic electrospun scaffolds. Biomed Mater. 2013;8:055009 pubmed publisher
  111. Motomura K, Izumi T, Tateishi S, Sumino H, Noguchi A, Horinouchi T, et al. Correlation between the area of high-signal intensity on SPIO-enhanced MR imaging and the pathologic size of sentinel node metastases in breast cancer patients with positive sentinel nodes. BMC Med Imaging. 2013;13:32 pubmed publisher
  112. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed publisher
  113. Hosokawa M, Kenmotsu H, Koh Y, Yoshino T, Yoshikawa T, Naito T, et al. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. PLoS ONE. 2013;8:e67466 pubmed publisher
  114. Ohta K, Taki M, Ogawa I, Ono S, Mizuta K, Fujimoto S, et al. Malignant ossifying fibromyxoid tumor of the tongue: case report and review of the literature. Head Face Med. 2013;9:16 pubmed publisher
  115. Nassiri F, Scheithauer B, Corwin D, Kaplan H, Mayberg M, Cusimano M, et al. Invasive thymoma metastatic to the cavernous sinus. Surg Neurol Int. 2013;4:74 pubmed publisher
  116. Sigurdsson V, Ingthorsson S, Hilmarsdottir B, Gustafsdottir S, Franzdóttir S, Arason A, et al. Expression and functional role of sprouty-2 in breast morphogenesis. PLoS ONE. 2013;8:e60798 pubmed publisher
  117. Yang G, Li J, Jin H, Ding H. Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study. Diagn Pathol. 2013;8:14 pubmed publisher
  118. Reichert M, Takano S, von Burstin J, Kim S, Lee J, Ihida Stansbury K, et al. The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis. Genes Dev. 2013;27:288-300 pubmed publisher
  119. Weli S, Aamelfot M, Dale O, Koppang E, Falk K. Infectious salmon anaemia virus infection of Atlantic salmon gill epithelial cells. Virol J. 2013;10:5 pubmed publisher
  120. Carrasco M, Delgado I, Soria B, Martin F, Rojas A. GATA4 and GATA6 control mouse pancreas organogenesis. J Clin Invest. 2012;122:3504-15 pubmed publisher
  121. Lv S, Song Y, Xu J, Shu H, Zhou Z, An N, et al. A novel TP53 somatic mutation involved in the pathogenesis of pediatric choroid plexus carcinoma. Med Sci Monit. 2012;18:CS37-41 pubmed
  122. Sohn W, Gwon G, An C, Moon C, Bae Y, Yamamoto H, et al. Morphological evidences in circumvallate papilla and von Ebners' gland development in mice. Anat Cell Biol. 2011;44:274-83 pubmed publisher
  123. Khoja L, Backen A, Sloane R, Menasce L, Ryder D, Krebs M, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106:508-16 pubmed publisher
  124. Kap M, Smedts F, Oosterhuis W, Winther R, Christensen N, Reischauer B, et al. Histological assessment of PAXgene tissue fixation and stabilization reagents. PLoS ONE. 2011;6:e27704 pubmed publisher
  125. Brusevold I, Husvik C, Schreurs O, Schenck K, Bryne M, Søland T. Induction of invasion in an organotypic oral cancer model by CoCl2, a hypoxia mimetic. Eur J Oral Sci. 2010;118:168-76 pubmed publisher
  126. Gil da Costa R, Santos M, Amorim I, Lopes C, Pereira P, Faustino A. An immunohistochemical study of feline endometrial adenocarcinoma. J Comp Pathol. 2009;140:254-9 pubmed publisher
  127. Rhee K, Wu S, Wu X, Huso D, Karim B, Franco A, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun. 2009;77:1708-18 pubmed publisher
  128. Rodriguez F, Scheithauer B, Giannini C, Bryant S, Jenkins R. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer. 2008;113:2779-89 pubmed publisher
  129. Lu S, Yu G, Zhu Y, Archer M. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer. 2005;116:847-52 pubmed
  130. Gilbert S, Loranger A, Marceau N. Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells. Mol Cell Biol. 2004;24:7072-81 pubmed
  131. Song S, Park S, Kim S, Suh Y. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas. Pathol Int. 2004;54:603-10 pubmed
  132. Kokenyesi R, Murray K, Benshushan A, Huntley E, Kao M. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression. Gynecol Oncol. 2003;89:60-72 pubmed